Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
01/2008
01/10/2008WO2008003460A1 Process for the preparation of asenapine and intermediate products used in said process.
01/10/2008WO2007109334A3 Sip receptor modulating compounds and use thereof
01/10/2008US20080009495 Compound Containing Basic Group and Use Thereof
01/10/2008US20080009483 3-{[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]methyl}-N-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-4-hydroxycyclopentanecarboxamide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
01/10/2008US20080009450 Genipin derivatives and uses thereof
01/10/2008CA2659060A1 Fused heterocyclic inhibitors of d-amino acid oxidase
01/10/2008CA2655723A1 Compositions and methods of making a photoactive agent
01/10/2008CA2655670A1 Process for the preparation of asenapine and intermediate products used in said process
01/09/2008EP1874779A1 Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
01/09/2008EP1874768A2 Inhibitors of akt activity
01/09/2008EP1283043B1 Ophthalmic solution
01/09/2008CN101103120A Methods for the production of ansamitocins
01/08/2008US7317100 C4-demethyl-epothilones or C4-bisnor-epothilones from reacting 2S,6R,7S,9S)-6,7-Epoxy-9-hydroxy-2,6,10-trimethyl-11-(2-methyl-4-thiazolyl)-undec-10-en-1-al with and ethylketone carboxylic acid; macrolactonizing the acid; antitumor, anticancer, antiproliferative
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
01/08/2008US7317021 Cancers that express nitric oxide synthase; 2-[2-(2-Amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine
01/08/2008CA2334298C Neuropeptide y5 receptor antagonists
01/08/2008CA2296031C Novel spiroazabicyclic heterocyclic compounds
01/08/2008CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/03/2008WO2008001859A1 OPIOID δ RECEPTOR AGONIST
01/03/2008WO2008000818A1 Fluorinated indoleamides useful as ligands of the orl-1 receptor
01/03/2008WO2008000645A1 Tetrazole-substituted arylamides
01/03/2008WO2007133756A3 Crf1 receptor ligands comprising heteroaryl fused bicycles
01/03/2008WO2005044008A3 2 -aminothiophene compounds as fungicides
01/03/2008US20080004327 Fluoro-substituted inhibitors of d-amino acid oxidase
01/03/2008US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period
01/03/2008CA2654915A1 Tetrazole-substituted arylamides
01/02/2008EP1873150A1 Fluorinated indoleamides useful as ligands of the ORL-1 receptor
01/02/2008EP1873147A1 Phthalazinone derivative and pharmaceutical comprising the same
01/02/2008EP1872797A2 Treatment of cardiovascular and related pathologies
01/02/2008EP1871761A2 Spirocyclic heterocyclic derivatives and methods of their use
01/02/2008EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
01/02/2008EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
01/02/2008EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/02/2008CN101098695A Pyranouidole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
01/02/2008CN100358898C Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
01/01/2008US7314932 Methods for minimizing thioamide impurities
01/01/2008US7314886 Tetrahydropyrano-indole derivatives
01/01/2008US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases
01/01/2008US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
12/2007
12/27/2007WO2007149560A2 Fermentation and purification of actinomadura chromoprotein and related species
12/27/2007WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES
12/27/2007WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007WO2007147480A2 Polymorphic forms and process
12/27/2007WO2007127175A3 Pharmaceutical compounds
12/27/2007WO2007064914A3 5-(arylsulfonyl)-pyrazolopiperidines
12/27/2007WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299119 Prophylactic or Therapeutic Agent for Severe Diabetic Retinopathy
12/27/2007US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299099 Acid Addition Salt of Irinotecan
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070298969 used as pesticides and/or pre- or postemergence herbicides
12/27/2007US20070298968 2,4,6-Phenyl-Substituted Cyclic Ketoenols
12/27/2007CA2656064A1 Polymorphic forms and process
12/27/2007CA2656034A1 Fused [d]pyridazin-7-ones
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007CA2654175A1 Fermentation and purification of actinomadura chromoprotein and related species
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007EP0850646B1 Liposome preparations of indolocarbazole derivatives
12/26/2007CN101094856A 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives
12/26/2007CN101094855A 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives
12/26/2007CN101094838A Tubulin binding anticancer agents and prodrugs thereof
12/26/2007CN101092420A (1Z, 4Z, 5Z) ¿C 6 N isopropyl ¿C 6 - aza ¿C2 ¿C oxo ¿C 3 - oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/26/2007CN101092419A (1Z, 4Z, 5Z) ¿C 6 N alkyl ¿C 6 ¿C aza ¿C2 ¿C oxo ¿C 3 ¿C oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/25/2007US7312242 Use of parthenolide derivatives as antileukemic and cytotoxic agents
12/25/2007US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312228 Cytotoxic indeno and isoindoloisoquinolones
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312212 Bactericides for infrections in man
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics
12/21/2007WO2007144379A1 Bicyclic compounds useful as cathepsin s inbhibitors
12/21/2007WO2007144200A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
12/21/2007WO2006083916A3 Novel adenosine a3 receptor modulators
12/20/2007US20070293686 cyanation; dopamine autoreceptor agonists and partial agonists at postsynaptic dopamine D2 receptor; for treating dopaminergic disorders such as schizophrenia, schizoaffective disorder, Parkinson's disease, Tourette's syndrome, hyperprolactinemia, and drug addiction
12/20/2007US20070293556 Prophylactic or Therapeutic Agent for Diabetic Maculopathy
12/20/2007US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer
12/20/2007US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/19/2007EP1867638A1 Procedure for the Conection of two Molecules via Diels-Alder Reactions with Inverse Electron Demand
12/19/2007EP1866316A2 Cytoskeletal active compounds, composition and use
12/19/2007EP1866315A1 1,2,4-triazole derivatives and their use as oxytocin antagonists
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1866081A1 Manufacture of lactones
12/19/2007EP1771450B1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/19/2007EP1286999B1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
12/19/2007EP1004140B1 A well to substrate photodiode for use in a cmos sensor on a salicide process
12/19/2007EP0804440B1 Tricyclic benzazepine vasopressin antagonists
12/19/2007CN100355756C Therapeutic agent for schizophrenia
12/18/2007US7309789 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
12/18/2007US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
12/13/2007WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/13/2007WO2007087549A3 Chemical compounds